| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bd. Co-chair, President &CSO | President and Chief Scientific | President and CSO +2 more
1 company
Yancopoulos George is a Bd. Co-chair, President &CSO at REGN. Recent filings cover 0 purchases and 90 sales. Those positions are worth an estimated $239.7M at current prices.
Our model assigns Yancopoulos George a middling insider score of 50/100, based on 9 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +4.8%.
Yancopoulos George's largest disclosed position is in REGN as Bd. Co-chair, President &CSO, worth about $239.7M. The recent filings there lean toward selling, a net 566,479 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CSO | Sell10b5-1 | 50,000 | $972.73 | $48,636,545.34 | -6.0% | +19.5% | -38.6% | |
| May 15, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CSO | Sell10b5-1 | 50,000 | $975.87 | $48,793,727.12 | -5.6% | +18.4% | -40.2% | |
| Jan 2, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CSO | Sell10b5-1 | 16,848 | $900.00 | $15,163,200.00 | -8.6% | +7.1% | -21.0% | |
| Jan 2, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CSO | Sell10b5-1 | 16,848 | $900.00 | $15,163,200.00 | -8.6% | +7.1% | -21.0% | |
| Mar 23, 2023 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sell | 3,656 | $804.26 | $2,940,374.33 | -1.8% | -2.9% | +20.6% | |
| Feb 6, 2023 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sell | 13,189 | $800.08 | $10,552,255.12 | -6.2% | -3.7% | +20.1% | |
| Aug 16, 2021 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sell | 50,000 | $625.29 | $31,264,263.45 | -5.3% | +3.0% | +3.2% | |
| Aug 5, 2021 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sell | 50,000 | $600.06 | $30,003,000.00 | -5.1% | +8.2% | +1.8% | |
| Jun 21, 2021 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sell | 80,000 | $538.90 | $43,112,141.09 | -97.4% | +20.0% | +10.0% | |
| Mar 10, 2020 | REGN Regeneron Pharmaceuticals, Inc. | President and Chief Scientific | Sale+OE | 117,815 | $470.47 | $55,428,041.05 | -18.5% | - | - |